One-third of patients with primary localized pleomorphic rhabdomyosarcoma may be cured, although the roles of chemotherapy and radiotherapy in this outcome are unclear.
Approximately one-third of patients with primary localized pleomorphic rhabdomyosarcoma may be cured, but the specific impact of chemotherapy and radiotherapy on this cure rate is not yet clear.
Absolute Event Rate: 0% vs 0%
While P-RMS is known to be an aggressive histologic sarcoma subtype, one-third of patients with primary localized disease may be cured. The contribution of chemotherapy and radiotherapy to the cure rate remains unclear. Post-metastatic outcomes mirror those observed in other sarcomas.
Giani et al. (Tue,) reported a other. One-third of patients with primary localized pleomorphic rhabdomyosarcoma may be cured, although the roles of chemotherapy and radiotherapy in this outcome are unclear.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: